133 related articles for article (PubMed ID: 4118428)
21. In vivo growth inhibition of L1210 leukemia by 4-amidinoindan-1-one 2'-amidinohydrazone (CGP 48664A), a new inhibitor of S-adenosylmethionine decarboxylase.
Dorhout B; Te Velde RJ; Ferwerda H; Kingma AW; De Hoog E; Muskiet FA
Int J Cancer; 1995 Apr; 61(2):214-7. PubMed ID: 7705950
[TBL] [Abstract][Full Text] [Related]
22. [Effect of dioxadet on tumors transplanted to the brain].
Stukov AN; Korsakov MV; Khrapova TN; Kil'maeva NE; Kraĭz BO
Vopr Onkol; 1986; 32(10):64-7. PubMed ID: 3776129
[TBL] [Abstract][Full Text] [Related]
23. Influence of route of administration on antileukemic activity of cyclocytidine.
Hoshi A; Kanzawa F; Kuretani K
Gan; 1972 Apr; 63(2):279-80. PubMed ID: 5070242
[No Abstract] [Full Text] [Related]
24. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
Porter CW; Bernacki RJ; Miller J; Bergeron RJ
Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
[TBL] [Abstract][Full Text] [Related]
25. [Significance of polyamines for the early diagnosis of spontaneous hemoblastoses in AKR mice].
Voronchikhina LD; Vorozhtsova SI; Minakov VN; Zinov'ev IuV; Shkanakina TP
Vopr Onkol; 1988; 34(2):200-4. PubMed ID: 3348011
[TBL] [Abstract][Full Text] [Related]
26. Aliphatic chain length specificity of the polyamine transport system in ascites L1210 leukemia cells.
Porter CW; Miller J; Bergeron RJ
Cancer Res; 1984 Jan; 44(1):126-8. PubMed ID: 6690029
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
WU FY; Le Pecq JB
Mol Pharmacol; 1983 Jan; 23(1):182-9. PubMed ID: 6346048
[No Abstract] [Full Text] [Related]
28. Antitumor effects of the antispermatogenic agent, 2,3-dihydro-2-(1-naphthyl)-4(1H)-quinazolinone (NSC-145669).
Neil GL; Li LH; Buskirk HH; Moxley TE
Cancer Chemother Rep; 1972 Apr; 56(2):163-73. PubMed ID: 5043224
[No Abstract] [Full Text] [Related]
29. Polyamines in the developing rat and in supportive tissues.
Russel DH; McVicker TA
Biochim Biophys Acta; 1972 Jan; 259(2):247-58. PubMed ID: 5060076
[No Abstract] [Full Text] [Related]
30. Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo.
Lu LJ; Randerath K
Mol Pharmacol; 1984 Nov; 26(3):594-603. PubMed ID: 6208475
[TBL] [Abstract][Full Text] [Related]
31. Polyamine accumulation and biosynthesis in a mouse L1210 leukemia.
Russell DH; Levy CC
Cancer Res; 1971 Mar; 31(3):248-51. PubMed ID: 5547211
[No Abstract] [Full Text] [Related]
32. Evaluation of antileukemic agents employing advanced leukemia L1210 in mice. VII.
Venditti JM; Sheldon DR; Goldin A
Cancer Res; 1964 Jan; 24(1 Pt 1):145-210. PubMed ID: 5878215
[No Abstract] [Full Text] [Related]
33. Polyamine biogenesis in left ventricle of the rat heart after aortic constriction.
Feldman MJ; Russell DH
Am J Physiol; 1972 May; 222(5):1199-203. PubMed ID: 4259993
[No Abstract] [Full Text] [Related]
34. Mutants of Saccharomyces cerevisiae deficient in polyamine biosynthesis: studies on the regulation of ornithine decarboxylase.
Tabor CW
Med Biol; 1981 Dec; 59(5-6):272-8. PubMed ID: 7040829
[TBL] [Abstract][Full Text] [Related]
35. Potential inhibitors of polyamine biosynthesis. 2. alpha-Alkyl- and benzyl-(+/-)-ornithine.
Abdel-Monem MM; Newton NE; Ho BC; Weeks CE
J Med Chem; 1975 Jun; 18(6):600-4. PubMed ID: 1151975
[TBL] [Abstract][Full Text] [Related]
36. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Seidler FJ; Trepanier PA; Whitmore WL; Lerea L; Barnes GA; Weigel SJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):741-5. PubMed ID: 6809932
[TBL] [Abstract][Full Text] [Related]
37. Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency.
Venditti JM; Baratta MC; Greenberg NH; Abbott BJ; Kline I
Cancer Chemother Rep; 1972 Aug; 56(4):483-92. PubMed ID: 5081591
[No Abstract] [Full Text] [Related]
38. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
Chabner BA; Chello PL; Bertino JR
Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
[No Abstract] [Full Text] [Related]
39. Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice.
Kelly CJ; Gaudio L; Yesair DW; Schoenemann PT; Wodinsky I
Cancer Treat Rep; 1978 Jul; 62(7):1025-32. PubMed ID: 80268
[TBL] [Abstract][Full Text] [Related]
40. Polyamines and transfer RNA-methylation in mouse leukemic cells.
Hacker B; McDermott BJ
Physiol Chem Phys; 1972; 4(1):41-55. PubMed ID: 4583019
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
